Global Lung Cancer Screening Software Market – Industry Trends and Forecast to 2026

  • Healthcare IT
  • Upcoming Report
  • Aug 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Lung Cancer Screening Software Market By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Lung Cancer Screening Software Market

Global lung cancer screening software market is expected to register a healthy CAGR of 19.63% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the various clinical trial initiated for cancer treatment requiring frequent diagnosis and screening to test the effectiveness of the trial.

Market Definition: Global Lung Cancer Screening Software Market

Lung cancer screening software can be defined as the software offering, which is designed to automate the workflow of healthcare facilities by collecting all of the diagnostic results gathered from CT, X-Ray and MRI machines. This results in enhancement of  the workflow operability in these facilities. The implementation of this software helps in better patient tracking, assessment of disease stage, next step of action, reporting and keeping a systemized data of patient information.

Market Drivers

  • Increasing prevalence of lung cancer cases globally is expected to boost the growth of the market
  • Increasing awareness regarding the benefits of early diagnosis and frequent screening acts as a market driver
  • Variety of government initiatives undertaken to implement screening programs for various diseases can also drive the market growth

Multiple benefits such as identification, tracking, enrollment, patient data integration, analytics, communication with physicians helps in better organization of workflow in healthcare facilities which can fuel the growth of this market

Market Restraints

  • Lack of awareness regarding the screening programs and its benefits in developing regions of the world is expected to hinder the growth of the market
  • Dearth of technically knowledgeable professionals for cancer diagnosis is expected to restrict the market growth
  • Lack of funding and other resources from  various regions for cancer and associated disorders can also hamper the market growth

Segmentation: Global Lung Cancer Screening Software Market

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In November 2018, Eon announced that they will provide 170 “EonDirect LCSR (Lung Cancer Screening Registry)” software licenses amounting upto USD 1 million to provide radiology centers, clinics and hospital facilities with enhanced screening service in comparison to the conventional manual tracking utilized. EonDirect registers and tracks patients for lung cancer screening through its cloud-based application system keeping a systematic track of the patient data
  • In November 2018, Lungview announced the launch of an upgraded lung cancer screening software with the availability of “LungView Luminary” on the new website. The upgraded tracking system helps physicians in keeping a record of patients, and following-up with them on their screening programs. The upgraded version provides optional node tracking, incidental findings tracking and dose information

Competitive Analysis:

Global lung cancer screening software market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of lung cancer screening software market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global lung cancer screening software market are PENRAD TECHNOLOGIES, INC.; Eon; Koninklijke Philips N.V.; Kheiron Medical Technologies; Volpara Solutions Limited; Thynk Health; CRA Health LLC; ProVation Medical, Inc.; Nuance Communications, Inc.; Siemens Healthcare GmbH; CureMetrix, Inc.; MyCareWare Inc.; MobileODT; MRS Systems, Inc.; Lungview and Vital Images among others.

Research Methodology: Global Lung Cancer Screening Software Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global lung cancer screening software market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE